Cui LZ, Zhao YW, Pan Y, et al. Onco Targets Ther. 2017;10:5817–5826.
The authors have advised that there is an error in Figure 5A on page 5823. During figure assembly, the Magnification 10x images for panels Control and PF562271 were switched in error.
The correct Figure 5 is as follows.
Figure 5.
The influence of the FAK inhibitor PF562271 (PF) on the VP-16-induced repopulation of SKOV3 cells.
Notes: (A) Representative images of the crystal violet staining assay of the receptor cells with the FAK inhibitor PF562271 (PF) added to the system. (B) The stained cells of the four groups in A were solubilized with 1 mL of 33% acetic acid and quantified by the absorbance at 570 nm. The results are expressed as the mean ± SD of three independent experiments, n=3, *P<0.05 compared with the control group, #P<0.05 compared with the model group.
Abbreviations: FAK, focal adhesion kinase; VP-16, etoposide phosphate; SD, standard deviation.
The authors apologise for this error and advise it does not affect the results of the paper.